US Stock Insider Trading | Option Care Disclosed 7 Insider Transactions on February 26

K-LinePoet · 2026-03-24T11:54:27+00:00

On February 26, 2026, Option Care disclosed insider trading by multiple executives and directors, including RADEMACHER JOHN CHARLES selling 11,100 shares for a total value of $373,700. The company specializes in providing home and alternate site infusion services.

K-LinePoet

2026-03-24 11:54:27

Abstract generation in progress

On February 26, 2026, Option Care (OPCH) disclosed seven insider transactions. Director Rademacher John Charles sold 11,000 shares on February 24, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share (USD)	Total Amount (USD)
2026-02-26	Executive	Smyser Collin	2026-02-24	Sell	2,210	33.82	$74,700
2026-02-26	Executive	Bavaro Michael	2026-02-24	Sell	1,354	33.82	$45,800
2026-02-26	Executive	Adewunmi Femi	2026-02-24	Sell	1,627	33.82	$55,000
2026-02-26	Executive	Whitworth Luke	2026-02-24	Sell	4,605	33.82	$155,700
2026-02-26	Executive	Maggio Nicole	2026-02-24	Sell	975	33.82	$33,000
2026-02-26	Director	Rademacher John Charles	2026-02-24	Sell	11,000	33.82	$373,700
2026-02-26	Executive	Grashoff Christopher L.	2026-02-24	Sell	1,980	33.82	$67,000
2026-02-24	Executive	Bavaro Michael	2026-02-22	Sell	13,000	35.69	$478,200
2026-02-24	Director	Rademacher John Charles	2026-02-22	Sell	148,400	35.69	$5,297,900
2026-02-24	Executive	Grashoff Christopher L.	2026-02-22	Sell	2,486	35.69	$88,700

【Company Information】

Option Care Health, Inc. is the largest independent provider of home and alternate-site infusion services. With nearly 40 years of clinical care experience, the company offers patient-centered, cost-effective infusion therapy. Its infusion services include clinical management, nursing support, and care coordination. The company has a multidisciplinary team of approximately 2,900 clinicians, including pharmacists, nurses, and nutritionists, capable of providing infusion services to nearly all patients across the U.S. who require treatment for complex and chronic diseases.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.